2421 Results for "

decrease

" in MedChemExpress (MCE) Product Catalog:
Products (2421)

2421 Results for "decrease" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-W007894
CAS No.: 595-46-0
Synonyms: Dimethylpropanedioic acid
Dimethylmalonic acid (Dimethylpropanedioic acid) is a succinate dehydrogenase inhibitor. Dimethylmalonic acid competitively inhibits succinate dehydrogenase, reduces SDH-mediated succinate accumulation, blocks a key step in oxidative phosphorylation, and decreases anti-inflammatory cytokine secretion and ROS production. Dimethylmalonic acid can be used in research on autism spectrum disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109058
CAS No.: 648927-86-0
Purity:  ≥98.0%
Synonyms: QGC001; RB150
Firibastat (QGC001), an orally active brain penetrating proagent of EC33, is a first-in-class brain aminopeptidase A (APA) inhibitor (Ki=200 nM). Firibastat selectively and specifically inhibits conversion of brain angiotensin-II into angiotensin-III and decreases blood pressure in hypertensive rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1776AS1
CAS No.: 1313734-84-7
Spermidine- 13C4 (hydrochloride) is the 13C-labeled Spermidine trihydrochloride. Spermidine hydrochloride maintains cell membrane stability, increases antioxidant enzymes activities, improving photosystem II (PSII), and relevant gene expression. Spermidine hydrochloride significantly decreases the H2O2 and O2.- contents .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1776R
CAS No.: 124-20-9
Spermidine (Standard) is the analytical standard of Spermidine. This product is intended for research and analytical applications. Spermidine maintains cell membrane stability, increases antioxidant enzymes activities, improving photosystem II (PSII), and relevant gene expression. Spermidine significantly decreases the H2O2 and O2.- contents .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-16516
CAS No.: 1085703-32-7
Research Areas:  

Cancer

Vitamin CK3 is the combination of Vitamin C and vitamin K3 (100:1 ratio). Vitamin CK3 can decrease MMP activity. Vitamin CK3 can reactivate DNases and cause cell autophagy. Vitamin CK3 can be used for the research of cancer, such as lung cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N8481
CAS No.: 108238-41-1
Synonyms: 3,6-DHF
Target:  

Apoptosis

Research Areas:  

Cancer

3,6-Dihydroxyflavone is an anti-cancer agent. 3,6-Dihydroxyflavone dose- and time-dependently decreases cell viability and induces apoptosis by activating caspase cascade, cleaving poly (ADP-ribose) polymerase (PARP). 3,6-Dihydroxyflavone increases intracellular oxidative stress and lipid peroxidation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W014332
CAS No.: 102-06-7
1,3-Diphenylguanidine is a widely used accelerator in rubber vulcanization. 1,3-Diphenylguanidine increases ROS activity and decreases SOD and CAT activity. 1,3-Diphenylguanidine accelerates the vulcanization process. 1,3-Diphenylguanidine impairs the reproduction and growth of Moina macrocopa [1] [2] [3] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-Y1819
CAS No.: 93-08-3
2-Acetonaphthone is a synthetic fragrance material. 2-Acetonaphthone increases ROS under UVA/sunlight, leading to endoplasmic reticulum stress and decreased mitochondrial membrane potential. 2-Acetonaphthone can be used as an adulterant in a variety of cosmetics. 2-Acetonaphthone can be used for the study of skin keratinization
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107855
CAS No.: 674-26-0
Purity:  99.15%
Synonyms: (±)-Mevalonolactone; Mevalolactone
DL-Mevalonolactone ((±)-Mevalonolactone;Mevalolactone) is the δ-lactone form of mevalonic acid, a precursor in the mevalonate pathway. DL-Mevalonolactone is orally active against HMGCR mutation and statin caused myopathy . DL-Mevalonolactone induces inflammation and oxidative stress response with decreased mitochondrial membrane potential (MMP) and induces mitochondrial swelling [2][4].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2204
CAS No.: 6980-25-2
Swertiajaponin is a tyrosinase inhibitor, forms multiple hydrogen bonds and hydrophobic interactions with the binding pocket of tyrosinase, with an IC50 of 43.47 μM. Swertiajaponin also inhibits oxidative stress-mediated MAPK/MITF signaling, leading to decrease in tyrosinase protein level. Swertiajaponin suppresses melanin accumulation and exhibits strong anti-oxidative activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W011824R
CAS No.: 2140-76-3
2′-O-Methyluridine (Standard) is the analytical standard of 2′-O-Methyluridine (HY-W001824). This product is intended for research and analytical applications. 2’-O-Methyluridine is a modified nucleoside that can be found in T. thermophile tRNA. 2’-O-Methyluridine level in serum is decreased in patients with breast cancer.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112056
CAS No.: 151358-48-4
Purity:  99.47%
DIM-C-pPhCO2Me is a nuclear receptor 4A1 (NR4A1) antagonist. DIM-C-pPhCO2Me induces Apoptosis. DIM-C-pPhCO2Me decreases PAX3-FOXO1A, N-Myc, Rassf4, MyoD1, Grem1, and DAPK1 proteins. DIM-C-pPhCO2Me decreases expression of TXNDC5 and IDH1, induces markers of ER stress (CHOP, ATF4 and p-PERK). DIM-C-pPhCO2Me inhibits renal cell carcinoma, breast cancer. DIM-C-pPhCO2Me can also be used in rhabdomyosarcoma research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99291
CAS No.: 892553-42-3
Synonyms: LM609; MEDI-522

Target:  

Integrin Apoptosis Akt

Research Areas:  

Cancer

Etaracizumab (LM 609) is an αvβ3 integrin IgG mAb. Etaracizumab is developed to target αvβ3+ cancer cells via NK cell-mediated cytotoxicity. Etaracizumab sterically hinders access of large ligands to the RGD-binding pocket, without obstructing it. Etaracizumab decreases p-Akt in vitro. Etaracizumab can decrease cancer proliferation and invasion. Etaracizumab induces tumor cell apoptosis, and inhibition ofαvβ3-mediated cell adhesion, endothelial cell migration and osteoclast-mediated bone resorption. Etaracizumab can be studied in anti-tumor research against cancers such as ovarian cancer, metastatic melanoma as well as advanced solid tumors. Recommend Isotype Control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116147
CAS No.: 1402830-75-4
Purity:  99.25%
Target:  

LPL Receptor Apoptosis

Research Areas:  

Cancer

Ceranib-2 is a potent and nonlipid ceramidase inhibitor that inhibits cellular ceramidase activity with an IC50 of 28 μM in SKOV3 cells. Ceranib-2 induces the accumulation of multiple ceramide species, decreases levels of sphingosine and sphingosine-1-phosphate (S1P), and induces cell apoptosis. Anticancer activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1452
CAS No.: 156897-06-2
Synonyms: ML-3000
Target:  

COX Lipoxygenase Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Licofelone (ML-3000) is a dual COX/5-lipoxygenase (5-LOX) inhibitor (IC50=0.21/0.18 μM, respectively) for the treatment of osteoarthritis. Licofelone exerts anti-inflammatory and anti-proliferative effects. Licofelone induces apoptosis, and decreases the production of proinflammatory leukotrienes and prostaglandins .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P0170
CAS No.: 885340-08-9
Research Areas:  

Inflammation/Immunology

TB500 is a synthetic version of an active region of thymosin β4. TB500 exhibits anti-fibrotic and wound healing activities by inhibiting the Akt signaling pathway and binding to actin. TB500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decrease inflammation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101415
CAS No.: 303-97-9
Purity:  ≥98.0%
Synonyms: Ubiquinone Q9; CoQ9; Ubiquinone 9
Coenzyme Q9 (Ubiquinone Q9), the major form of ubiquinone in rodents, is an amphipathic molecular component of the electron transport chain that functions as an endogenous antioxidant. Coenzyme Q9 attenuates the diabetes-induced decreases in antioxidant defense mechanisms. Coenzyme Q9 improves left ventricular performance and reduces myocardial infarct size and cardiomyocyte apoptosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110181
CAS No.: 883976-12-3
Purity:  99.89%
Target:  

TRP Channel

Research Areas:  

Metabolic Disease

M8-B is a potent transient receptor potential melastatin-8 (TRPM8) antagonist. M8-B blocks cold-induced and TRPM8-agonist-induced activation TRPM8 channels. M8-B decreases deep body temperature (Tb) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-176557
CAS No.: 907547-06-2
NCI677397 is a USP24 inhibitor. NCI677397 increases lipid ROS, activates cholesterol and fatty acid biosynthesis, degrades ABC transporters, GPX4 and DHFR through the autophagy pathway, decreases the level of P-gp and ultimately leads to ferroptosis in drug-resistant cancer cells. NCI677397 can be used for the study of lung caner and brain cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0111
CAS No.: 67392-87-4
Synonyms: Dihydrospirorenone
Drospirenone (Dihydrospirorenone) is an orally active fourth-generation progestin that interacts with the progesterone receptor (PR) and androgen receptor (AR). Drospirenone significantly decreases both plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) via the AR. Drospirenone can produce DNA damage in bone marrow cells of female mice. .
loading...
    loading...